Scenic Biotech appoints Ben Machielse to its Board of Directors

– NETHERLANDS, Amsterdam –  Scenic Biotech, a pioneer in the field of modifier therapies for severe diseases, today announced the appointment of Ben Machielse to its Board of Directors, bringing over 25 years of experience in the biotech industry with proven expertise in leading the development of therapeutics through clinical evaluation up to market approval in start-ups and fully integrated companies.…

Talent4Boards
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.